Bridgepoint Acquires RoC Skincare

a selection of RoC Skincare products on a beige background

Bridgepoint, a London-listed investment firm, has reportedly acquired RoC Skincare from San Francisco’s Gryphon Investors. The transaction is valued at approximately $500 million, according to an anonymous source.

Gryphon Investors initially acquired the renowned skincare brand from Johnson & Johnson Consumer Inc in 2019, though the details of that deal remain undisclosed.

Founded in 1957 by French pharmacist Dr. Jean-Charles Lissarrague, New York-based RoC Skincare is known for its innovative anti-ageing products that are available globally.

With €39.5 billion in assets under management, Bridgepoint has a history of strategic investments in the beauty and skincare industry, which includes the acquisition of French cosmetics company VIVACY in 2022. It also owned HTL Biotechnology, a producer of the skincare ingredient hyaluronic acid, which it sold in 2021 to a consortium led by Montagu for an undisclosed sum.

Subscribe to our newsletter

Stay up-to-date with the latest from BeautyNewsDaily.

By subscribing, you agree to the Privacy Policy and give your consent to receive BeautyNewsDaily emails. We won't share your data, and you can unsubscribe at any time.


You are now subscribed to BeautyNewsDaily.

Something went wrong

We had an issue subscribing your email address. Please check your spelling and try again. If you still have an issue, please contact

Already subscribed

It appears you are already subscribed to our newsletter. If you are not receiving emails then please contact